- Home
- RVSN vs GOVX Comparison
RVSN vs GOVX Comparison
Compare RVSN & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSN
- GOVX
- Stock Information
- Founded
- RVSN 2016
- GOVX 2001
- Country
- RVSN Israel
- GOVX United States
- Employees
- RVSN N/A
- GOVX N/A
- Industry
- RVSN
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- RVSN
- GOVX Health Care
- Exchange
- RVSN Nasdaq
- GOVX Nasdaq
- Market Cap
- RVSN 20.5M
- GOVX 16.8M
- IPO Year
- RVSN 2022
- GOVX N/A
- Fundamental
- Price
- RVSN $0.66
- GOVX $0.56
- Analyst Decision
- RVSN
- GOVX Strong Buy
- Analyst Count
- RVSN 0
- GOVX 3
- Target Price
- RVSN N/A
- GOVX $10.67
- AVG Volume (30 Days)
- RVSN 12.1M
- GOVX 1.0M
- Earning Date
- RVSN 08-22-2025
- GOVX 11-11-2025
- Dividend Yield
- RVSN N/A
- GOVX N/A
- EPS Growth
- RVSN N/A
- GOVX N/A
- EPS
- RVSN N/A
- GOVX N/A
- Revenue
- RVSN $776,000.00
- GOVX $6,143,044.00
- Revenue This Year
- RVSN $1,861.54
- GOVX N/A
- Revenue Next Year
- RVSN N/A
- GOVX N/A
- P/E Ratio
- RVSN N/A
- GOVX N/A
- Revenue Growth
- RVSN N/A
- GOVX 1943.07
- 52 Week Low
- RVSN $0.27
- GOVX $0.43
- 52 Week High
- RVSN $2.72
- GOVX $3.88
- Technical
- Relative Strength Index (RSI)
- RVSN 80.66
- GOVX 38.26
- Support Level
- RVSN $0.46
- GOVX $0.54
- Resistance Level
- RVSN $0.99
- GOVX $0.59
- Average True Range (ATR)
- RVSN 0.10
- GOVX 0.04
- MACD
- RVSN 0.04
- GOVX -0.00
- Stochastic Oscillator
- RVSN 70.61
- GOVX 40.38
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.